Adding pegylated interferon to entecavir improves hepatitis B treatment response
Adherence to hepatitis C treatment: unravelling the complexities
Is a simple sofosbuvir plus ribavirin regimen suitable for difficult-to-treat hepatitis C patients?
HIV and hepatitis C co-infection increases the risk of cognitive impairment
Hepatitis C patients with cirrhosis respond well to boceprevir or telaprevir with careful monitoring
Brivanib fails to match sorafenib for liver cancer, but tivantinib looks promising
Telaprevir and VX-222 pair well in interferon-free regimen, VX-135 on the horizon
